An expert panel of the World Health Organization (WHO) has advised against the use of the antiviral drug remdesivir for patients admitted to hospital with COVID-19, regardless of how severely ill they are as no evidence existed currently to prove that it improves survival or the need for ventilation. WHO Guideline Development Group based its […]
